5-METHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE, 95%, 25g

(2E)-1-(2-chlorophenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

3,5-Bis(trifluoromethyl)aniline>97.0%(GC)10g

Anti-6xHis Monoclonal Antibody (6A12)1vial

4,5-Difluoro-2-iodophenol, 97%, 5g

4-(METHOXYCARBONYL)-4-METHYLCYCLOHEXANECARBOXYLIC ACID, 95.0%, 250mg

Fmoc-4-(4-methoxyphenyl)-L-phenylalanine, 98%, 1g

2-Aminoethanethiol>95.0%(T)25g

Benzyl (S)-2-(((benzyloxy)carbonyl)amino)-4-oxobutanoate, 97%, 1g

Benzamide, N-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)-, 5mg

N-(4-(N-(pyridin-4-yl)sulfamoyl)phenyl)acetamide, 97%, 1g

ethyl 3-bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate, 100mg

2-Amino-N,N-diethylpropanamide hydrochloride, 95.0%, 5g